Monsanto, Bayer officials defend proposed $66 billion merger
Bayer aims to expedite innovation at the Consumer Health business mainly by pursuing regulatory approval for over-the-counter (OTC) status for products that were previously only available with a prescription (Rx-to-OTC switches) and through the development of new digital health...
Posted On Sep 24 2016